Penumbra Share Price

Penumbra Share Price

NYSE: PEN | Large Cap | Healthcare
$319.14
-$0.69 (-0.22%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Penumbra Stock Performance

Open
$319.71
Prev. Close
$319.83
Circuit Range
N/A
Day Range
$319.05 - $320.19
Year Range
$277.76 - $362.39
Volume
20,758
Average Traded
$319.67

Penumbra Share Price Today

As of 21 November 2026, Penumbra, Inc.'s share price is $319.14. The stock opened at $319.71, compared to its previous close of $319.83. During today's trading session, Penumbra, Inc.'s share price traded between $319.05 and $320.19, with an average price of $319.62. Over the past 52 weeks, the stock has recorded a high of $362.39 and a low of $277.76. In terms of performance, Penumbra, Inc.'s share price has risen by 0.27% over the last six months and is up 8.94% on a year-on-year basis.

Penumbra Share Price Chart

Line chart of the Penumbra price trend over the selected period. The price fell overall, ranging from 319.06 to 320.23, ending at 319.14.
$319.05$320.19
L
Show Current Price
H

Penumbra Stock Fundamentals & Key Indicators

Market Cap
$12.42B
PE Ratio (TTM)
80.33
Dividend Yield
0.00%
EPS (TTM)
$3.98
Revenue (TTM)
$1.40T
Return On Equity (TTM)
9.92%
Profit Margin
12.66%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-10.69%

Penumbra Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$385.39$374.76$390.05$410.15
Net Profit$47.34$32.58$34.81$42.28
Net Profit Margin12.28%8.69%8.92%10.31%
Income ChangeN/A-31.18%6.84%21.46%

Penumbra Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$847.13$1058.52$1194.62$1403.67
Net Profit-$2.00$90.95$14.01$177.69
Net Profit Margin-0.24%8.59%1.17%12.66%
Income ChangeN/A4647.50%-84.60%1168.31%

Penumbra Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets609.84582.06640.9615.19
Current Assets1216.68951.13915.4755.7
Total Assets1826.521533.181556.311370.89
Non Current Liabilities215.78223.91226.22227.1
Current Liabilities183.13158.35151.14144.93
Total Liabilities398.92382.25377.36372.03
Shareholders' Equity1427.61150.931178.94998.86

Penumbra Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating238.66168.4897.33-55.66
Investing-404.5977.62-16.0854.79
Financing26.53-87.0116.211.62

About Penumbra

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Penumbra Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$319.20
$319.06
+0.13%
Oct 2026
$318.51
$318.66
+0.06%
Sep 2026
$322.54
$318.48
-0.93%
Aug 2026
$322.12
$321.46
+0.11%
Jul 2026
$317.10
$321.11
+1.78%
Jun 2026
$318.86
$315.50
-0.87%
May 2026
$326.22
$318.27
-2.49%
Apr 2026
$329.01
$326.40
-0.53%
Mar 2026
$342.51
$328.14
-4.70%
Feb 2026
$358.82
$344.34
-3.91%
Jan 2026
$310.10
$358.34
+15.10%
Dec 2025
$294.02
$311.34
+6.28%

Penumbra Share Price FAQs